Items tagged with Drug-resistant TB
Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort study (post)
Abstract
Decreased time to treatment initiation for multidrug-resistant tuberculosis patients after use of Xpert MTB/RIF test, Latvia (post)
Abstract
International advanced course on clinical management of drug-resistant tuberculosis for WHO Europe Region countries, 2016 (post)
The course is organized by the World Health Organization (WHO) Collaborating center for research and training in management of multidrug-resistant tuberculosis (MDR-TB) of Latvia.
Presentation: Clofazimine - repurpose & strategy, January 29 (post)
Roxana Drake, MD, PhD from Novartis will give a presentation on January 29, 2016 from 09:00 to 10:00 EST (15:00-16:00 CET) entitled Clofazimine – repurpose & strategy.
Lung surgery improves treatment success for MDR-TB (post)
Partial lung resection in addition to antibiotic therapy improved treatment outcomes among patients with multidrug-resistant tuberculosis, according to recent data.
Issues in design and interpretation of MDR-TB clinical trials: report of the first Global MDR-TB Clinical Trials Landscape Meeting (post)
Abstract
Building clinical trial capacity to develop a new treatment for multidrug-resistant tuberculosis (post)
Abstract
India: Drug-resistant TB detection within 2 hours (post)
For the task, the ministry has procured 500 GeneXpert machines that will provide results of drug-resistant TB within two hours against the conventional diagnostic tools which take up to two months.
Bedaquiline, new pill to treat MDR-TB, to arrive in India soon (post)
CHENNAI, February 7, 2016: Bedaquiline, a new drug to treat extensively drug-resistant tuberculosis (XDR-TB), will soon be introduced in government facilities at selected centres across the country, according to the Indian Council of Medical Research (ICMR).
Page 24 of 117 · Total posts: 0
←First 23 24 25 Last→